Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05297500 · ClinicalTrials.gov registry record

Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031)

A clinical trial of Hypoxia, sponsored by Nihon Kohden.

Active
Registry status
12
Enrollment target
1
Study location

NCT05297500 is a study of Hypoxia that is active but no longer recruiting, run by Nihon Kohden. The registered enrollment target is 12 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05297500, a study of Hypoxia, is active but no longer recruiting, sponsored by Nihon Kohden.

ACTIVE NOT RECRUITING
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest

Conditions Studied

Interventions

  • DEVICE Pulse oximeter

Study Locations (1)

California

  • UCSF Hypoxia Research Laboratory - San Francisco

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-03-23
Est. Completion 2026-10-29

Sponsor

Nihon Kohden

14 total trials

What the Registry Record Tells You About NCT05297500

The ClinicalTrials.gov registry entry for NCT05297500 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The listed sponsor is Nihon Kohden, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse oximeter is the first listed.

NCT05297500 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05297500 about?

NCT05297500 is a clinical study titled "Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031)". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest

What is the current status of trial NCT05297500?

This trial is currently active not recruiting. The enrollment target is 12 participants. The study started on 2022-03-23. Estimated completion is 2026-10-29.

What conditions does trial NCT05297500 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT05297500?

The interventions under investigation include: Pulse oximeter (DEVICE).

Who is sponsoring clinical trial NCT05297500?

This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05297500 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.